Delivery Order SPE2DE24D0013-SPE2D625F2URV
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, has been awarded a delivery order valued at $1,605.00 under contract GXMRSA-NXG-10, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is funded by the Defense Medical Supply Chain, a defense-focused federal agency. The award represents Cepheid's continued provision of molecular diagnostic technologies and services to the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, has been awarded a delivery order valued at $8,533.57 under contract XPRS4PLEX-10 by the Medical Supply Chain, a Defense agency entity. The award, issued on August 29, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed-price pricing and does not include a set-aside designation. Performance will be conducted at Cepheid's Sunnyvale facility. This delivery order represents...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2URVDelivery Order
Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $22,926.50 by the Medical Supply Chain division of the Department of Defense on September 8, 2025, with a completion date of September 15, 2025. The delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's established relationship with federal healthcare agencies, particularly the Department of Defense and Department of Veterans Affairs, which have consistently procured the company's diagnostic equipment and testing solutions. Cepheid specializes in providing molecular diagnostic technologies including GeneXpert diagnostic systems, reagents, and test kits for detecting infectious diseases such as COVID-19, influenza, RSV, MRSA, and other clinical conditions. This delivery order likely supports the Defense Health Agency's operational and testing requirements. The award is positioned within Cepheid's broader federal contracting portfolio, which includes two significant Indefinite Delivery Vehicle contracts with the VA's Veterans Integrated Service Networks valued at over $35 million combined, demonstrating the company's critical role in supplying molecular diagnostic capabilities across multiple federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 9/8/25 |